SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Deals
What Biogen CFO’s Departure Means for Company’s M&A Strategy
June 15, 2017
 · 
2 min read
Alexion is Under Investigation by the HHS Office of Inspector General
Business
Alexion Poaches Biogen’s Longtime CFO
June 14, 2017
 · 
2 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
BioCapital
What Biogen Wants in Return for Financial Assistance of Its $750,000 a Year Drug
June 12, 2017
 · 
3 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Biogen Loses Yet Another Top Exec
May 26, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Business
Former Biogen Exec Launches Bain Capital’s First Life Sciences Fund With $750 Million
May 23, 2017
 · 
2 min read
3 Biotechs That Could be Taken Out This Quarter
Business
Biogen Spinoff Bioverativ Takes Out Bay Area’s True North in $825 Million Deal
May 23, 2017
 · 
3 min read
Pharm Country
Why Long-Term Investors Should Prefer Celgene Over Biogen
May 22, 2017
 · 
1 min read
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Business
Biogen’s CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant
May 15, 2017
 · 
3 min read
How Biogen Makes Most of Its Cash
Job Trends
More R&D Fat is Trimmed as Biogen Closes Doors on UK’s Convergence Pharma
May 12, 2017
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the Morgan Stanley Global Healthcare Conference
August 30, 2013
 · 
1 min read
Business
Adimab LLC. Cash Flow Goes Into the Black With Biogen Idec, Inc. (Massachusetts), GlaxoSmithKline Deals
July 26, 2013
 · 
3 min read
Business
Biogen Idec, Inc. (Massachusetts) Delivers Double-Digit Top & Bottom-Line Growth in Second Quarter 2013
July 25, 2013
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) Makes Move to Revamp Culture
July 25, 2013
 · 
1 min read
Policy
Biogen Idec, Inc. (Massachusetts): It’s Unlikely Patient Death Was Caused by New MS Drug
July 23, 2013
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Release: US and EU Regulatory Authorities Accept PLEGRIDY™ (peginterferon beta-1a) Marketing Applications for Review
July 19, 2013
 · 
1 min read
Policy
Genentech and Biogen Idec, Inc. (Massachusetts) Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case
July 16, 2013
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Present New Data From the Phase 3 Study of Their Long-Lasting Hemophilia Factor Candidate ELOCTATE™
July 8, 2013
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) to Report Second Quarter 2013 Financial Results on July 25, 2013
July 8, 2013
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts)'s Head R&D Exec Leaves Company
July 3, 2013
 · 
1 min read
Load More